NCT04775940CompletedNot Applicable
The Use of Perforated Barrier Membranes and IPRF Nano- Micro Sticky Bone in Horizontal Alveolar Ridge Augmentation - Controlled Clinical and Histomorphometric Study
Conditions
Interventions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Ain Shams University
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Horizontal alveolar bone width in mm
Study Overview
Brief Summary
Comparing amount of horizontal bone gain 4 months after alveolar ridge augmentation using IPRF Nano- micro Sticky Bone with perforated collagen membrane versus occlusive barrier membrane by :
- clinical and Radiographic analysis .
- Histomorphometric analysis .
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double (Participant, Outcomes Assessor)
Eligibility Criteria
- Ages
- 20 Years to 40 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Healthy adult patients.
- •Both sex, males and females. 3-Age from 20 - 40 years old. 4-All patients will be free from any systemic diseases as evidenced by Burkett's oral medicine health history questionnaire.
- •5-Remaining alveolar bone ≥ 8mm vertically and ≤ 4 mm horizontally. 6-Gingival biotype 1-2mm thickness.
Exclusion Criteria
- •Pregnant and breast feeding females.
- •Mentally retarded Patients.
- •Presence of hematologic disease.
- •Previous radiation, chemotherapy, or immunosuppressive treatments.
- •Diabetes mellitus, metabolic bone disease, ongoing treatment with bisphosphonates drugs, or pregnancy.
- •Anticoagulant drugs, Endocarditis risk factors, renal and hepatic failure
Arms & Interventions
Perforated collagen membrane
Experimental
Intervention: Perforated collagen membrane (Procedure)
Occlusive collagen membrane
Active Comparator
Intervention: Occlusive collagen membrane (Procedure)
Outcomes
Primary Outcomes
Horizontal alveolar bone width in mm
Time Frame: 6 months
Measured By Bone caliber and Cone Beam Computed Tomography (CBCT)
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Clinical efficacy of polycaprolactone membrane for bone augmentation in dental implant treatment: Pilot studyAdult patients (Aged 20-65 years)Good general health (ASA 1, 2) and not a contraindication for minor surgeryThe diagnosis and indications for guided bone regenerationDental implants, Guided bone regenerationTCTR20200526010Faculty of Dentistry, Thammasat University24
Completed
Not Applicable
Repeated Injection of I PRF and Autogenous Bone Graft for Alveolar Ridge AugmentationAlveolar Bone LossAlveolar Ridge AbnormalityNCT06711250Ain Shams University28
Withdrawn
Not Applicable
Vertical and Horizontal Mandibular Ridge Augmentation TechniquesVertical Ridge DeficiencyHorizontal Ridge DeficiencyNCT06636084University of Michigan32
Terminated
Not Applicable
Prospective, Comparative Assessment of Alveolar Bone Augmentation Using GUIDOR® Membrane in the Bound Edentulous SpaceBone RegenerationNCT02387008University of North Carolina, Chapel Hill6
Unknown
Not Applicable
Poly Tetra Fluro Ethylene vs Native Collagen Membrane for Gbr in Anterior MaxillaMissing Maxillary Anterior TeethNCT03839615Cairo University10
